Australia, Dec. 10 -- Neurizon Therapeutics Ltd. (NUZ) has reported gross short sales of 17,778 FPO shares on Dec. 6. The percent of issued capital of the company reported as short sales is 0.0 percent. The issued capital of the company is 491,905,766 shares.
Disclaimer: Curated by HT Syndication.